To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:
- • State issued document with your organization's Federal Tax ID Number
- • State issued document with your organization's Resale Tax ID Number
- • City or County issued Business License
- • State Department of Health Services License
- • Any other ID issued by the State that includes the business name & address
* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. VWR will not lift restrictions for residential shipping addresses.
Specifications
- Detection limit:~0.10 mg/dl
- Cat. no.:75817-140
- Includes:Kit contains: Standard, Reagents, and 96-Well Plate
- Supplier No.:700460-192
Specifications
About this item
For the measurement of creatinine levels in plasma and serum.
- Measure creatinine levels in plasma and serum
- Assay 40 samples in duplicate
- Assay range: 0.0625-50 µM
- Measure creatinine levels down to 0.1 mg/dl
- Plate-based colorimetric measurement (490-500 nm)
Creatinine is commonly measured in urine and is a key benchmark for the normalization of a variety of urinary biomarkers. Serum creatinine levels, however, are a useful indicator of renal function. In addition, abnormal creatinine levels have been implicated in diabetes, cardiovascular, and circulatory diseases. Cayman’s Creatinine (serum) Assay is designed to measure creatinine levels in plasma and serum. The assay relies on the Jaffe’ reaction, wherein a yellow/orange color forms when the metabolite is treated with alkaline picrate. The rate of color development is directly proportional to the concentration of creatinine in the sample and is measured at an absorbance between 490-500 nm. The kinetic nature of the assay eliminates interference from extraneous serum contaminants, such as lipids and bilirubin.